Medical Countermeasures New Insights Into Tularemia Pathogen May Inform Next-Generation Medical CountermeasuresGlobal Biodefense StaffMay 14, 2026
Medical Countermeasures When Mpox Strikes the Eye: A Case for Combination Antiviral TherapyGlobal Biodefense StaffApril 16, 2026
Medical Countermeasures Smallpox Preparedness Contracts Top $60 Million as U.S. and International Partners Bolster Biodefense StockpilesGlobal Biodefense StaffMarch 25, 2026
Novavax Updated Protein-Based COVID-19 Vaccine Authorized in the UK Medical Countermeasures January 24, 2024 …
BARDA Funds Next Stage of CRISPR-Based Bacteriophage Therapy Medical Countermeasures January 23, 2024 …
NanoViricides’ Phase 1 Broad-Spectrum Antiviral Highly Effective for Mpox and Smallpox Medical Countermeasures November 14, 2023 …
COVID Moonshot Consortium Announces Crowd-Sourced Small Molecule Discovery Medical Countermeasures November 11, 2023 …
Phase 2 Clinical Trial for Marburg Vaccine Starts in Uganda Medical Countermeasures October 19, 2023 …
Novavax’s Prototype COVID-19 Vaccine Nuvaxovid Receives Full Approval in Singapore Medical Countermeasures October 18, 2023 …
Jurata Thin Film and CastleVax Awarded Grant to Advance Thermostabilized COVID-19 Booster Medical Countermeasures September 20, 2023 …
Mount Sinai to Lead Development of Pan-Coronavirus Vaccine Under New Federal Grant Contracts + Grants September 17, 2023 …
Smallpox Vaccines: Bavarian Nordic Awarded Another Contract to Supply EU Strategic Reserve Medical Countermeasures September 13, 2023 …
HHS Extends Partnership with Regeneron to Develop Life-Saving Monoclonal Antibodies Contracts + Grants September 8, 2023 …
Kyasanur Forest Disease: Promising Experimental Vaccine for Rare Tick-borne Flavivirus Medical Countermeasures September 7, 2023 …
Disease X: CEPI and University of Oxford Collaborate on Rapid Response Vaccine Technology Medical Countermeasures August 29, 2023 …
Chikungunya Vaccine: Health Canada Moves Forward with Valneva Review Medical Countermeasures August 29, 2023 …
CSL Seqirus Awarded Contract for Influenza A(H5N8) Candidate Vaccine Medical Countermeasures August 28, 2023 …
